Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/10/010260
CTRI/2017/10/010260
Recruiting
未知

Assessment of changes in hypoxia related biomarkers during surgery in resectable non-small cell lung cancer

Tata Memorial Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Hospital
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with resectable non small cell lung cancer (NSCLC)who are planned for surgery and have not received any prior treatment

Exclusion Criteria

  • •Histological diagnosis other than non small cell lung cancer (NSCLC)or NSCLC Patients who have received prior treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of hypoxia using genetic and imaging biomarker in head and neck squamous cell carcinomaHead and neck cancerCancer
ISRCTN49555010Guy's and St Thomas' NHS Foundation Trust (UK)40
Recruiting
Not Applicable
Association of Hypoxia Measured by Oxygen Desaturation Index (ODI) in OSA with Delis-Kaplan Executive Function System (D-KEFS) Tests in Middle-Aged and Older AdultsObstructive sleep apneaCognitive impairmentMemoryExecutive functionElderlyMagnetic resonance imaging
TCTR20190805004Chulalongkorn University29
Recruiting
Not Applicable
Association of Hypoxia Measured by Oxygen Desaturation Index (ODI) in OSA with Delis-Kaplan Executive Function System (D-KEFS) Tests in Older AdultsObstructive sleep apneaCognitive impairmentMemoryExecutive functionElderlyMagnetic resonance imaging
TCTR20191124003Chulalongkorn University29
Not yet recruiting
Not Applicable
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancer
JPRN-UMIN000041659Saitama Medical University International Medical Center20
Completed
Not Applicable
Effects of oxygen status on Hypoxia Inducible Factor 1-a. A pilot proof of principle study.sepsisinfection in the blood1002766510002252
NL-OMON38504niversitair Medisch Centrum Sint Radboud20